P W Jeroen Maljaars

9PUBLICATIONS
12CO-AUTHORS
Behavioural epidemiologyImmunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Food properties (incl. characteristics and health benefits)Social epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 12, 2025
Modifiable Factors Influencing Disease Flares in Inflammatory Bowel Disease: A Literature Overview of Lifestyle, Psychological, and Environmental Risk Factors.

Lola J M Koppelman, Aroha A Oyugi, P W Jeroen Maljaars

|Jan 21, 2023
Frailty and Inflammatory Bowel Disease: A Scoping Review of Current Evidence.

Anne Fons, Kees Kalisvaart, Jeroen Maljaars

|Jul 23, 2022
Real-world experience of switching from intravenous to subcutaneous vedolizumab maintenance treatment for inflammatory bowel diseases.

Adriaan Volkers, Tessa Straatmijer, Marjolijn Duijvestein

|May 14, 2022
Comment on Szczubełek et al. Effectiveness of Crohn's Disease Exclusion Diet for Induction of Remission in Crohn's Disease Adult Patients. Nutrients 2021, 13, 4112.

Emilie van Lingen, Sander van der Marel, Jeroen Maljaars

|Sep 09, 2020
Comorbidity, not patient age, is associated with impaired safety outcomes in vedolizumab- and ustekinumab-treated patients with inflammatory bowel disease-a prospective multicentre cohort study.

Vera E R Asscher, Vince B C Biemans, Marieke J Pierik

|Jun 05, 2019
Towards a Food Pharmacy: Immunologic Modulation through Diet.

Ilse Molendijk, Sander van der Marel, P W Jeroen Maljaars

Pageof 2

Frequent Collaborators

2 joint publications

Vera E R Asscher

2 joint publications

Vince B C Biemans

1 joint publications

Mike van der Have

1 joint publications

Andrea van der Meulen-de Jong